Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study

BACKGROUND: Biologic therapies are often prescribed for patients with rheumatoid arthritis (RA) who have inadequate responses to or are intolerant of methotrexate (MTX) and patients with poor prognostic indicators. This post hoc analysis evaluated effectiveness and safety of intravenous golimumab + ...

Descripción completa

Detalles Bibliográficos
Autores principales: Broadwell, Aaron, Schechtman, Joy, Conaway, Douglas, Kivitz, Alan, Shiff, Natalie J., Black, Shawn, Xu, Stephen, Langholff, Wayne, Schwartzman, Sergio, Curtis, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045110/
https://www.ncbi.nlm.nih.gov/pubmed/36973741
http://dx.doi.org/10.1186/s41927-023-00329-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045110/
https://www.ncbi.nlm.nih.gov/pubmed/36973741
http://dx.doi.org/10.1186/s41927-023-00329-8

Ejemplares similares